Patients with personal or family history of MTC or Multiple Endocrine Neoplasia type 2 (MEN2) should avoid semaglutide and discuss alternative weight loss strategies with their physician
How Employers Are Managing GLP-1 Coverage Rather than eliminating coverage altogether, many employers are implementing structured management strategies designed to balance access, affordability, and outcomes
Can I use Cica with Retinol
For GLP-1 receptor agonist studies, the once-weekly dosing enabled by Semaglutide, Tirzepatide, and Retatrutide allows for more consistent plasma levels throughout multi-week metabolic research protocols
Presented to the 8th LWPES/ESPE Joint Meeting, New York, NY 2009
Your primary care physician, endocrinologist, or an expert specializing in diabetes management can assess your health status and determine whether youre a good candidate for the drug